Paclitaxel-eluting stent
Paclitaxel-eluting stent is a medical device with 8 clinical trials. Historical success rate of 87.5%.
Success Metrics
Based on 7 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
7
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
87.5%
7 of 8 finished
12.5%
1 ended early
0
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction
Effect of Rotablator on Balloon Resistant Calcified Coronary Lesion
Efficacy Study of Drug-eluting and Bare Metal Stents in Bypass Graft Lesions
Efficacy Study of Two Different Strategies for Restenosis in Sirolimus-Eluting Stents
A COMparison Between PAClitaxel-coated Balloon and pacliTaxel-eluting Stent in the Treatment of In-Stent Restenosis (COMPACT-ISR)
Clinical Trials (8)
Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction
Effect of Rotablator on Balloon Resistant Calcified Coronary Lesion
Efficacy Study of Drug-eluting and Bare Metal Stents in Bypass Graft Lesions
Efficacy Study of Two Different Strategies for Restenosis in Sirolimus-Eluting Stents
A COMparison Between PAClitaxel-coated Balloon and pacliTaxel-eluting Stent in the Treatment of In-Stent Restenosis (COMPACT-ISR)
Comparison of Paclitaxel-Eluting Coroflex Please Stent Versus Paclitaxel-Eluting Stent
Drug-eluting-stents for Unprotected Left Main Stem Disease (ISAR-LEFT-MAIN)
Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization
All 8 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 8